Distinction of cardiometabolic profiles among people ≥75 years with type 2 diabetes: a latent profile analysis

BMC Endocrine Disorders
Antoine ChristiaensSéverine Henrard

Abstract

Older patients with type 2 diabetes mellitus represent a heterogeneous group in terms of metabolic profile. It makes glucose-lowering-therapy (GLT) complex to manage, as it needs to be individualised according to the patient profile. This study aimed to identify and characterize subgroups existing among older patients with diabetes. Retrospective observational cohort study of outpatients followed in a Belgian diabetes clinic. Included participants were all aged ≥75 years, diagnosed with type 2 diabetes, Caucasian, and had a Homeostasis Model Assessment (HOMA2). A latent profile analysis was conducted to classify patients using the age at diabetes diagnosis and HOMA2 variables, i.e. insulin sensitivity (HOMA2%-S), beta-cell-function (HOMA2%-β), and the product between both (HOMA2%-βxS; as a measure of residual beta-cell function). GLT was expressed in defined daily dose (DDD). In total, 147 patients were included (median age: 80 years; 37.4% women; median age at diabetes diagnostic: 62 years). The resulting model classified patients into 6 distinct cardiometabolic profiles. Patients in profiles 1 and 2 had an older age at diabetes diagnosis (median: 68 years) and a lesser decrease in HOMA2%-S, as compared to other profiles. They...Continue Reading

References

Feb 23, 2010·Diabetes Research and Clinical Practice·Ping ZhangGregory Nichols
May 12, 2010·International Journal of Clinical Practice·S Del PratoUNKNOWN Global Partnership for Effective Diabetes Management
Feb 10, 2012·Journal of the American Geriatrics Society·Sara E EspinozaHelen Hazuda
Oct 27, 2012·Diabetes Care·M Sue KirkmanCarrie S Swift
Feb 12, 2013·Lancet·Andrew CleggKenneth Rockwood
Apr 26, 2013·BMJ : British Medical Journal·Laura A McLarenGerard A McKay
Apr 16, 2014·Diabetes Research and Clinical Practice·Trisha DunningStephen Colagiuri
Feb 1, 2014·Diabetes Spectrum : a Publication of the American Diabetes Association·Ruban Dhaliwal, Ruth S Weinstock
Dec 3, 2015·Current Obesity Reports·Lydia E GillJohn A Batsis
Feb 9, 2017·Diabetes Research and Clinical Practice·Siqin ZhangYerong Yu
Mar 23, 2017·Diabetes Care·Pearl G Lee, Jeffrey B Halter
Apr 25, 2017·Diabetes Research and Clinical Practice·K OgurtsovaL E Makaroff
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Aug 18, 2021·Endocrinology and Metabolism Clinics of North America·Chang Liu, Yan V Sun

❮ Previous
Next ❯

Software Mentioned

R
Homeostasis Model Assessment ( HOMA2
SPSS Statistics

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.